Related Experiment Video

Updated: Jun 12, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

[Development on timely first dose of hepatitis B vaccine for infants]

Yuan-sheng Hu1, Fu-qiang Cui, Xiao-feng Liang

  • 1The Center of the Disease Control and Prevention of Qinghai Province, Xining 810007, Qinghai, China.

Zhongguo Yi Miao He Mian Yi
|June 26, 2010
PubMed

Insights

Timely birth dose of hepatitis B vaccine (HepB) is crucial for infant protection. Further research is needed in low-coverage areas to identify barriers and improve HepB vaccination strategies.

Area of Science:

  • Immunology
  • Public Health
  • Pediatrics

Context:

  • Hepatitis B virus (HBV) infection poses a significant global health risk to infants.
  • The timely birth dose of the hepatitis B vaccine (HepB) is a critical preventive measure.
  • Current HepB birth dose coverage varies, with some regions experiencing low uptake.

Purpose:

  • To review the importance of the timely birth dose of the hepatitis B vaccine for infants.
  • To identify the need for further research in areas with low HepB birth dose coverage.
  • To determine influencing factors and develop intervention strategies to increase HepB birth dose administration.

Summary:

  • The article reviews studies on the timely administration of the hepatitis B vaccine at birth.
  • It highlights the necessity of targeted research in regions with suboptimal HepB birth dose coverage.
  • The research aims to uncover factors affecting vaccine uptake and devise strategies for improvement.

Impact:

  • Increased understanding of barriers to timely HepB vaccination.
  • Development of evidence-based interventions to improve HepB birth dose coverage.
  • Enhanced protection of infants against hepatitis B virus infection through timely vaccination.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Vaccinations01:51

Vaccinations

Overview